HCAT - Health Catalyst Non-GAAP EPS revenue beats FY22 guidance in-line with consensus
- Health Catalyst press release ( NASDAQ: HCAT ): Q3 Non-GAAP EPS of -$0.13 beats by $0.06 .
- Revenue of $68.35M (+10.7% Y/Y) beats by $1.56M .
- Q4 revenue expected to be between $66.9 million and $68.9 million, vs. consensus of $66.79M.
- FY22 revenue between $274.0 million and $276.0 million, vs. consensus of $274.0M
For further details see:
Health Catalyst Non-GAAP EPS, revenue beats, FY22 guidance in-line with consensus